Group 1 - Acumen Pharmaceuticals, Inc. (ABOS) is currently ranked 4 in the Zacks Sector Rank within the Medical group, which consists of 1063 companies [1] - The Zacks Rank for Acumen Pharmaceuticals is 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [2] - Year-to-date, Acumen Pharmaceuticals has returned 8.1%, outperforming the Medical sector's average return of 6.8% [2] Group 2 - Acumen Pharmaceuticals is part of the Medical - Biomedical and Genetics industry, which includes 512 companies and is currently ranked 80 in the Zacks Industry Rank [3] - The Medical - Biomedical and Genetics industry has shown an average gain of 0% year-to-date, indicating that Acumen Pharmaceuticals is performing better than its industry peers [3] - Ayr Wellness Inc. (AYRWF) is another Medical stock that has outperformed the sector with a year-to-date return of 12% and a Zacks Rank of 2 (Buy) [3]
Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?